Mark L - Home | Rare Diseases Clinical Research Network

The fulminant (H1), non-fulminant hepatic (H2), neurohepatic (N1) and neurological (NX) manifestations were 15.2%, 51.5%, 27.3% and 6.1%, respectively. The Kayer Fleischer ring was found in 100% patients with the neurological signs and symptoms but only 75.6% for the whole group. ................
................